Joanna Chorostowska-Wynimko
Laboratory of Molecular Diagnostics and Immunology
National Institute of Tuberculosis and Lung Diseases
Warsaw
Poland
Name/email consistency: high
- Neoadjuvant therapy affects tumor growth markers in early stage non-small-cell lung cancer. Chorostowska-Wynimko, J., Zaleska, J., Chabowski, M., Szpechcinski, A., Zych, J., Rudzinski, P., Langfort, R., Orlowski, T., Roszkowski-Sliz, K. Eur. J. Med. Res. (2009)
- Leptin measurement in urine is a reliable method of monitoring its secretion in patients with obstructive sleep apnea syndrome. Chorostowska-Wynimko, J., Pływaczewski, R., Jończak, L., Bednarek, M., Stepniewska, A., Borowska, A., Gorecka, D. J. Physiol. Pharmacol. (2007)
- Theophylline inhibits free oxygen radicals production by human monocytes via phosphodiesterase inhibition. Chorostowska-Wynimko, J., Kus, J., Skopińska-Rózewska, E. J. Physiol. Pharmacol. (2007)
- The impact of genetic markers on the diagnosis of lung cancer: a current perspective. Chorostowska-Wynimko, J., Szpechcinski, A. J. Thorac. Oncol (2007)
- In vitro angiomodulatory activity of sera from type 2 diabetic patients with background retinopathy. Chorostowska-Wynimko, J., Skopiński, P., Szaflik, J., Partyka, I., Duda-Król, B., Anuszewska, E., Skopińska-Rózewska, E. J. Physiol. Pharmacol. (2005)
- Disturbed angiogenic activity in sera from obstructive sleep apnea patients. Chorostowska-Wynimko, J., Radomska, D., Pływaczewski, R., Jończak, L., Stepniewska, A., Górecka, D., Skopińska-Rózewska, E. J. Physiol. Pharmacol. (2005)
- Plasminogen activator inhibitor type-1 mutants regulate angiogenesis of human umbilical and lung vascular endothelial cells. Chorostowska-Wynimko, J., Swiercz, R., Skrzypczak-Jankun, E., Selman, S.H., Jankun, J. Oncol. Rep. (2004)
- Multiple effects of theobromine on fetus development and postnatal status of the immune system. Chorostowska-Wynimko, J., Skopińska-Rózewska, E., Sommer, E., Rogala, E., Skopiński, P., Wojtasik, E. Int. J. Tissue. React (2004)
- Cellular components of the bronchoalveolar lavage correlate with lung function impairment and extrapulmonary involvement markers in active sarcoidosis. Chorostowska-Wynimko, J., Leśniewska-Radomska, D., Krychniak-Soszka, A., Remiszewski, P., Szopiński, J., Wesołowski, S., Kuś, J., Skopińska-Rózewska, E. J. Physiol. Pharmacol. (2004)
- Plasminogen activator inhibitor type-1 controls the process of the in vitro sprout formation. Chorostowska-Wynimko, J., Skrzypczak-Jankun, E., Jankun, J. J. Physiol. Pharmacol. (2004)
